Trial intelligence / Profile preview

Electrochemotherapy versus surgery for basal cell carcinoma

2010-019260-37Phase 4Completed

Sponsor
Cork Cancer Research Centre
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of bleomycin in basal cell carcinoma (BCC) (2 arms), sponsored by Cork Cancer Research Centre. Primary endpoint: Primary efficacy comparison. Started Jun 2010; status: completed.

02

Drugs

bleomycin
03

Conditions

basal cell carcinoma (BCC)

Beyond the preview

Go deeper on 2010-019260-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019260-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call